Inventor
XU ZHENRONG
US38 patents
⚠️ This page may combine multiple inventors who share the name “XU ZHENRONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VITAE PHARMACEUTICALS INC
10 patentsUS7872028B2Jan 18, 2011
Diaminopropanol renin inhibitors
VITAE PHARMACEUTICALS INC14 citations83
US7754737B2Jul 13, 2010
Diaminoalkane aspartic protease inhibitors
VITAE PHARMACEUTICALS INC16 citations83
US7858624B2Dec 28, 2010
Piperidine and morpholine renin inhibitors
VITAE PHARMACEUTICALS INC7 citations73
US9949975B2Apr 24, 2018
Inhibitors of beta-secretase
VITAE PHARMACEUTICALS INC1 citations62
US9526727B2Dec 27, 2016
Inhibitors of beta-secretase
VITAE PHARMACEUTICALS INC1 citations62
US10336717B2Jul 2, 2019
Inhibitors of beta-secretase
VITAE PHARMACEUTICALS INC1 citations61
US9090605B2Jul 28, 2015
Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
VITAE PHARMACEUTICALS INC0 citations52
US9045500B2Jun 2, 2015
Inhibitors of beta-secretase
VITAE PHARMACEUTICALS INC1 citations52
US9212153B2Dec 15, 2015
Inhibitors of beta-secretase
VITAE PHARMACEUTICALS INC1 citations51
US10654884B2May 19, 2020
Purine derivatives as CD73 inhibitors for the treatment of cancer
VITAE PHARMACEUTICALS INC0 citations41
CLAREMON DAVID A
8 patentsUS8138178B2Mar 20, 2012
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A37 citations92
US8440658B2May 14, 2013
Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A16 citations84
US8575156B2Nov 5, 2013
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A5 citations73
US8569292B2Oct 29, 2013
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A5 citations73
US8680281B2Mar 25, 2014
Lactam inhibitors of 11-β-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A3 citations63
US8673899B2Mar 18, 2014
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A3 citations63
US8754076B2Jun 17, 2014
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CLAREMON DAVID A0 citations52
US8927715B2Jan 6, 2015
Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
CLAREMON DAVID A0 citations42
BALDWIN JOHN J
6 patentsUS8198453B2Jun 12, 2012
Piperidine renin inhibitors
BALDWIN JOHN J3 citations61
US8580823B2Nov 12, 2013
Piperidine renin inhibitors
BALDWIN JOHN J0 citations51
US8106221B2Jan 31, 2012
Renin inhibitors
BALDWIN JOHN J1 citations51
US8455521B2Jun 4, 2013
Diaminoalkane aspartic protease inhibitors
BALDWIN JOHN J0 citations50
US8084485B2Dec 27, 2011
6-(aminoalkyl)indazoles
BALDWIN JOHN J0 citations40
US8487108B2Jul 16, 2013
Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors
BALDWIN JOHN J0 citations39
CACATIAN SALVACION
3 patentsUS8633212B2Jan 21, 2014
Inhibitors of beta-secretase
CACATIAN SALVACION10 citations81
US8748444B2Jun 10, 2014
Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
CACATIAN SALVACION0 citations50
US9079861B2Jul 14, 2015
Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
CACATIAN SALVACION0 citations39
PTC THERAPEUTICS INC
3 patentsUS12384789B2Aug 12, 2025
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations59
US11407753B2Aug 9, 2022
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations59
US11780839B2Oct 10, 2023
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations56